Invention Grant
US08632983B2 Biomarkers for pancreatic cancer and diagnostic methods 有权
胰腺癌生物标志物和诊断方法

Biomarkers for pancreatic cancer and diagnostic methods
Abstract:
Methods and related kits for differentiating pancreatic cancer from a benign pancreatic disease. The method includes assaying a patient biological sample for a total level of CA 19-9 antigen and for a glycan level in specific mucin(s), and comparing the total level of CA 19-9 antigen and the glycan level in the specific mucin(s) to statistically validated thresholds, wherein a different level of total CA 19-9 antigen in the patient biological sample as compared to a statistically validated threshold and a different level of glycan level in the specific mucin(s) as compared to statistically validated thresholds indicate pancreatic cancer in the patient rather than a benign pancreatic disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0